In The News Posted October 1, 2020 Share Posted October 1, 2020 ALBANY, N.Y., Oct. 1, 2020 /PRNewswire/ -- A CAGR of 3.8% will be recorded by the global autoimmune disease diagnostics market from 2019 to 2027. Valuation will go up from USD 14.4 billion in the year 2018 to USD 20.1 billion by the end of the forecast period. It is significant to note...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.